Journal Information
Vol. 44. Issue S2.
Pages S207 (October 2022)
Share
Share
Download PDF
More article options
Vol. 44. Issue S2.
Pages S207 (October 2022)
Open Access
ATM DNA METHYLATION ASSOCIATED WITH POOR PROGNOSIS AND LEUKEMIA TRANSFORMATION IN MYELODYSPLASTIC SYNDROME PATIENTS
Visits
498
VS Oliveiraa,b,c, MC Bragaa,b, CS Montea,b, MA Vianaa,b,c, LR Sampaioa,b,c, JVC Goesa,b,d, GFA Pinheiroa,b,e, NFA Minetea,b,c, RF Pinheiroa,b,c,e,f, SMM Magalhãesa,b,c,f
a Laboratório Citogenômico do Câncer, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
b Núcleo de Pesquisa e Desenvolvimento de Medicamentos (NPDM), Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
c Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
d Programa de Pós-Graduação em Patologia, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
e Departamento de Medicina Clínica, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
f Programa de Pós-Graduação em Medicina Translacional, Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 44. Issue S2
More info

Myelodysplastic syndrome (MDS) is a clonal disease of hematopoietic progenitors with a risk of progressing to acute myeloid leukemia. MDS etiology is mainly related to age, but one of the risk factors is exposure to pesticides that causes aberrant reprogramming of the genome by DNA methylation. The aim of this work was evaluating the methylation profile of genes acting in the single-strand DNA (ssDNA) repair (CSA, CSB, XPA, XPC and XPG) and double-strand DNA (dsDNA) repair (ATM, BRCA1, BRCA2, LIG4 and RAD51), and its relationship with gene expression. The analysis was performed using bone marrow samples from 56 MDS patients, 69 farmers exposed to pesticides and 10 controls without exposition or MDS. The methylation profile and gene expression were evaluated using pyro-sequencing technique and quantitative real-time PCR. Regarding ssDNA repair genes, in cases with MDS, patients under 60 years old showed a higher methylation for the XPA and CSB genes than patients over 60 years old (p = 0.008; p = 0.017). Furthermore, XPA showed increased methylation levels in initial forms of MDS (p = 0.019). The MDS group presented a higher percentage of XPA methylation than exposed farmers (p = 0.000) and the control group (p = 0.011). In the prognostic classification, lower risk presented higher methylation than high-risk (p = 0.027). Among the dsDNA repair genes methylation in MDS patients, only ATM gene showed significant results with increase of methylation levels in (1) males (p = 0.037); (2) patients aged up to 60 years (p = 0.002) and (3) those who progressed to AML (p = 0.016). Regarding the methylation between the groups of exposed farmers, MDS advanced forms and controls, we also detected significant differences with levels always increased in the control group: ATM (control group vs. farmers p = 0.000), BRCA1 exposed vs. control group, p = 0.001; MDS vs. control, p = 0.001;), BRCA2 (farmers vs. control, p = 0.027; MDS vs. control, p = 0.004), LIG4 (farmers vs. control, p = 0.001; MDS vs. control, p = 0.012) and RAD51 (farmers vs. controls, p = 0.047). The correlation analysis between methylation and expression showed a positive and strong correlation for LIG4 gene in the advanced forms MDS group (r = 0.798) and a positive and weak correlation for BRCA1 gene in the exposed farmers group (r = 0.340). Surprisingly, in the ssDNA repair genes, the expression and methylation of both farmers and MDS patients were not correlated, suggesting that the change in the expression of these genes is not motivated by the DNA methylation mechanism. Furthermore, the analysis of dsDNA repair genes in this study corroborates the phenomenon of relative hypermethylation in some DNA repair genes in MDS.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools